Acknowledgements H.C
Tri-Immune injections are often used: During cold and flu season Around travel or increased exposure to illness At the first signs of immune stress As part of a short preventive protocol during times of increased demand on the body For patients who want proactive immune support, this therapy can be a helpful tool
Individual outcomes can differ
Given the lack of data and potential risks, avoiding these supplements while breastfeeding represents the prudent choice
What stands out: Enforcement focus on mass-marketing, not patient-specific compounding Clear limits on advertising claims, including prohibitions on calling compounded products generic, the same as, or clinically proven Reinforcement of FD&C Act authorities, including misbranding provisions and Section 503A requirements Shift as shortages resolve, removing the legal basis for broad compounding of GLP-1 drugs Expanded compliance tools, including warning letters, seizure, and injunction where violations persist Bottom line: This signals a firmer FDA posture as the GLP-1 market matures, reinforcing long-standing distinctions between FDA-approved drugs and unapproved compounded preparations, particularly when promoted directly to consumers at scale
Given its health advantages, ACV has grown in favor of a potential weight-control tool
